Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjornsson

Showing results (131-140 of 584) with videos related to

Pageof 59
Sort By:
Journal of Clinical Pharmacology|November 1, 1994
Estimation of pharmacokinetic parameters for simulations of time courses of drug concentrations after oral administrationT D Bjornsson, N L Lui, M J England
European Journal of Clinical Pharmacology|July 29, 1998
Effect of food on the absorption of eptastigmineT D Bjornsson, W M Troetel, B P Imbimbo
Clinical Pharmacology and Therapeutics|January 1, 1982
Heparin kinetics determined by three assay methodsT D Bjornsson, K M Wolfram, B B Kitchell
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo dispositionT D Bjornsson, D E Schneider, A R Hecht
Cell Differentiation|December 1, 1975
Granulocyte differentiation by Friend leukemia cellsH D Preisler, S Bjornsson, M Mori, et al.
Journal of Pharmaceutical Sciences|January 1, 1977
High-pressure liquid chromatographic analysis of drugs in biological fluids I. WarfarinT D Bjornsson, T F Blaschke, P J Meffin
Journal of Chromatography|July 11, 1977
High-pressure liquid chromatographic analysis of drugs in biological fluids. IV. Determination of clofibrinic acidT D Bjornsson, T F Blaschke, P J Meffin
Dialogues in Clinical Neuroscience|July 14, 2010
Body dysmorphic disorderAndri S Bjornsson, Elizabeth R Didie, Katharine A Phillips
Alimentary Pharmacology & Therapeutics|August 27, 2009
Review article: nuclear receptors and liver disease--current understanding and new therapeutic implicationsD A H Elfaki, E Bjornsson, K D Lindor
Laeknabladid|August 15, 2009
[Health-related quality of life.]T Helgason, J K Bjornsson, K Tomasson, et al.
Pageof 59

Showing results (131-140 of 584) with videos related to

Sort By:
Pageof 59
Journal of Clinical Pharmacology|November 1, 1994
Estimation of pharmacokinetic parameters for simulations of time courses of drug concentrations after oral administrationT D Bjornsson, N L Lui, M J England
European Journal of Clinical Pharmacology|July 29, 1998
Effect of food on the absorption of eptastigmineT D Bjornsson, W M Troetel, B P Imbimbo
Clinical Pharmacology and Therapeutics|January 1, 1982
Heparin kinetics determined by three assay methodsT D Bjornsson, K M Wolfram, B B Kitchell
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo dispositionT D Bjornsson, D E Schneider, A R Hecht
Cell Differentiation|December 1, 1975
Granulocyte differentiation by Friend leukemia cellsH D Preisler, S Bjornsson, M Mori, et al.
Journal of Pharmaceutical Sciences|January 1, 1977
High-pressure liquid chromatographic analysis of drugs in biological fluids I. WarfarinT D Bjornsson, T F Blaschke, P J Meffin
Journal of Chromatography|July 11, 1977
High-pressure liquid chromatographic analysis of drugs in biological fluids. IV. Determination of clofibrinic acidT D Bjornsson, T F Blaschke, P J Meffin
Dialogues in Clinical Neuroscience|July 14, 2010
Body dysmorphic disorderAndri S Bjornsson, Elizabeth R Didie, Katharine A Phillips
Alimentary Pharmacology & Therapeutics|August 27, 2009
Review article: nuclear receptors and liver disease--current understanding and new therapeutic implicationsD A H Elfaki, E Bjornsson, K D Lindor
Laeknabladid|August 15, 2009
[Health-related quality of life.]T Helgason, J K Bjornsson, K Tomasson, et al.
Pageof 59